GCK Polyclonal Antibody

Hexokinases phosphorylate glucose to produce glucose-6-phosphate, the first step in most glucose metabolism pathways. Alternative splicing of GCK results in three tissue-specific forms of glucokinase, one found in pancreatic islet beta cells and two found in liver. Glucokinase localizes to the outer membrane of mitochondria. In contrast to other forms of hexokinase, this enzyme is not inhibited by its product glucose-6-phosphate but remains active while glucose is abundant. Mutations in this gene have been associated with non-insulin dependent diabetes mellitus (NIDDM), maturity onset diabetes of the young, type 2 (MODY2) and persistent hyperinsulinemic hypoglycemia of infancy (PHHI).

The GCK Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of glucokinase (GCK) protein in various biological samples. This antibody is produced using advanced recombinant DNA technology, ensuring high purity and batch-to-batch consistency.

The GCK Polyclonal Antibody exhibits exceptional affinity and specificity towards GCK, a key enzyme involved in glucose metabolism. It recognizes both the active and inactive forms of GCK, enabling comprehensive analysis of its expression and activity levels. This antibody has been extensively validated in various experimental settings, including Western blotting, immunohistochemistry, and immunofluorescence.

With its superior sensitivity, the GCK Polyclonal Antibody allows for accurate and reliable detection of GCK even at low expression levels. Its robust performance ensures consistent and reproducible results, making it an ideal choice for both research and diagnostic applications.

The GCK Polyclonal Antibody is supplied in a convenient and ready-to-use format, eliminating the need for time-consuming preparation. It is available in various sizes to accommodate different experimental requirements. Each batch of the antibody undergoes rigorous quality control tests to ensure optimal performance and reliability.

In summary, the GCK Polyclonal Antibody is a highly reliable and efficient tool for the detection and quantification of GCK protein. Its exceptional sensitivity, specificity, and ease of use make it an invaluable asset for researchers and clinicians working in the field of glucose metabolism and related disorders.